RT Journal Article
SR Electronic
T1 Optimising activity and diet compositions for dementia prevention: Protocol for the ACTIVate prospective longitudinal cohort study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.28.21261299
DO 10.1101/2021.07.28.21261299
A1 Smith, Ashleigh E.
A1 Wade, Alexandra T.
A1 Olds, Timothy S.
A1 Dumuid, Dorothea
A1 Breakspear, Michael J.
A1 Laver, Kate E.
A1 Goldsworthy, Mitchell R.
A1 Ridding, Michael C.
A1 Fabiani, Monica
A1 Dorrian, Jillian
A1 McKewen, Montana
A1 Paton, Bryan
A1 Abdolhoseini, Mahmoud
A1 Aziz, Fayeem
A1 Mellow, Maddison L.
A1 Collins, Clare E.
A1 Murphy, Karen
A1 Gratton, Gabriele
A1 Keage, Hannah A.D.
A1 Smith, Ross T.
A1 Karayanidis, Frini
YR 2021
UL http://medrxiv.org/content/early/2021/07/31/2021.07.28.21261299.abstract
AB Introduction Approximately 40% of late-life dementia may be prevented by addressing modifiable risk factors, including physical activity and diet. Yet, it is currently unknown how multiple lifestyle factors interact to influence cognition. The ACTIVate Study aims to 1) Explore associations between 24-hour time-use and diet compositions with changes in cognition and brain function; and 2) Identify durations of time-use behaviours and the dietary compositions to optimise cognition and brain function.Methods and analysis This three-year prospective longitudinal cohort study will recruit 448 adults aged 60-70 years across Adelaide and Newcastle, Australia. Time-use data will be collected through wrist-worn activity monitors and the Multimedia Activity Recall for Children and Adults (MARCA). Dietary intake will be assessed using the Australian Eating Survey food frequency questionnaire. The primary outcome will be cognitive function, assessed using the Addenbrooke’s Cognitive Examination-III (ACE-III). Secondary outcomes include structural and functional brain measures using Magnetic Resonance Imaging (MRI), cerebral arterial pulse measured with Diffuse Optical Tomography (Pulse-DOT), neuroplasticity using simultaneous Transcranial Magnetic Stimulation (TMS) and Electroencephalography (EEG), and electrophysiological markers of cognitive control using event-related potential (ERP) and time-frequency analyses. Compositional data analysis, testing for interactions between time-point and compositions, will assess longitudinal associations between dependent (cognition, brain function) and independent (time-use and diet compositions) variables.Conclusions The ACTIVate Study will be the first to examine associations between time-use and diet compositions, cognition and brain function. Our findings will inform new avenues for multidomain interventions that may more effectively account for the co-dependence between activity and diet behaviours for dementia prevention.Ethics and dissemination Ethics approval has been obtained from University of South Australia’s Human Research Ethics committee (202639). Findings will be disseminated through peer reviewed manuscripts, conference presentations, targeted media releases and community engagement events.Registration Details Australia New Zealand Clinical Trials Registry (ACTRN12619001659190).Strengths and limitationsThe ACTIVate Study will collect comprehensive measures of lifestyle behaviours and dementia risk over time in 448 older adults aged 60-70 years.Using newly developed Compositional Data Analysis (CoDA) techniques we will examine the associations between time-use and diet compositions, cognition and brain function.Data will inform the development of a digital tool to help older adults obtain personalised information about how to reduce their risk of cognitive decline based on changes to time use and diet.Recruitment will be focussed on older adults to maximise the potential of making an impact on dementia prevention in the next 10 years.Findings may not be generalisable to younger adults.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialAustralia New Zealand Clinical Trials Registry (ACTRN12619001659190)Funding StatementThe ACTIVate study is funded by a National Health and Medical Research Council (NHMRC) Boosting Dementia Research Initiative (BDRI) priority round 5 grant (GNT1171313). A.E.S. is supported by an NHMRC-ARC Dementia Research Development Fellowship (GNT1097397). D.D. is supported by an NHMRC Early Career Fellowship (GNT1162166) and the National Heart Foundation of Australia (1020840). M.R.G. is supported by an Australian Research Council (ARC) fellowship (DE200100575). M.L.M. is supported by a Dementia Australia Research Foundation PhD scholarship. C.E.C. is supported by an NHMRC Senior Research Fellowship and a University of Newcastle Faculty of Health and Medicine Gladys M Brawn Senior Research Fellowship. H.A.D.K. is supported by a NHMRC Boosting Dementia Research Leadership Fellowship (GNT1135676).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics approval has been obtained from University of South Australias Human Research Ethics committee (202639).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesOnce the ACTIVate study is complete, de-identified data will be made available to other research groups upon reasonable request. To obtain an ethically compliant data set (with de-identified data) researchers will contact the corresponding author and provide evidence of institutional ethics approval for local data storage, analysis and security.